ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,00%
S&P 500
5.431,60
0,00%
US Dollar vs BRL
5,40239
0,97%
Bitcoin
65.526,94
-1,67%
Brent Oil
82,545
0,51%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAFW)

  7. bioAffinity Technologies Inc (BIAFW) Notícias

BIAFW

bioAffinity Technologies (BIAFW)

bioAffinity Technologies Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIAFW
DataHoraFonteTítuloCódigoCompanhia
14/06/202421:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFWbioAffinity Technologies Inc
12/06/202409:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFWbioAffinity Technologies Inc
05/06/202417:30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIAFWbioAffinity Technologies Inc
05/06/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFWbioAffinity Technologies Inc
22/05/202417:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BIAFWbioAffinity Technologies Inc
15/05/202411:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIAFWbioAffinity Technologies Inc
15/05/202410:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFWbioAffinity Technologies Inc
02/05/202409:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
24/04/202409:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFWbioAffinity Technologies Inc
09/04/202409:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFWbioAffinity Technologies Inc
01/04/202410:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
08/03/202414:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
06/03/202411:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFWbioAffinity Technologies Inc
30/01/202410:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFWbioAffinity Technologies Inc
08/01/202410:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFWbioAffinity Technologies Inc
05/12/202310:00Business WirebioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of DirectorsNASDAQ:BIAFWbioAffinity Technologies Inc
30/11/202310:00Business WireCMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024NASDAQ:BIAFWbioAffinity Technologies Inc
28/11/202310:00Business WirebioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology PostNASDAQ:BIAFWbioAffinity Technologies Inc
14/11/202318:01Business WirebioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
06/11/202310:00Business WirebioAffinity Technologies Names Dallas J. Coleman as National Director of SalesNASDAQ:BIAFWbioAffinity Technologies Inc
10/10/202309:00Business WirebioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
07/09/202309:00Business WirebioAffinity Technologies to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:BIAFWbioAffinity Technologies Inc
14/08/202318:03Business WirebioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:BIAFWbioAffinity Technologies Inc
12/07/202309:00Business WireAMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung CancerNASDAQ:BIAFWbioAffinity Technologies Inc
15/06/202309:00Business WirebioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
22/05/202309:00Business WirebioAffinity Technologies Presents Research Findings at CYTO 2023NASDAQ:BIAFWbioAffinity Technologies Inc
01/05/202309:00Business WirebioAffinity Technologies Names Michael Dougherty as Chief Financial OfficerNASDAQ:BIAFWbioAffinity Technologies Inc
25/04/202309:00Business WirebioAffinity Technologies Presents at Cleveland Clinic Lung Cancer SymposiumNASDAQ:BIAFWbioAffinity Technologies Inc
31/03/202318:52Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial ResultsNASDAQ:BIAFWbioAffinity Technologies Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BIAFW

Seu Histórico Recente

BOV
COGN3
COGNA ON
BOV
IBOV
Índice Bovespa
BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
BOV
HAGA3
HAGA ON
BOV
JHSF3
JHSF PART ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados